KEVIN HO: Open Payments
NPI 1811587116 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 25 payments from 10 companies in 2025. Trend: 2023 $1,510 · 2024 $327 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $343 |
| Teva Pharmaceuticals USA, Inc. | 2 | $92 |
| Vanda Pharmaceuticals Inc. | 1 | $89 |
| Otsuka America Pharmaceutical, Inc. | 1 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $71 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Lundbeck LLC | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Alkermes, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
Products named: COBENFY, UZEDY, FANAPT, ABILIFY MAINTENA, CAPLYTA, Auvelity, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across MS — which companies pay providers there.
